Additionally, polymorphisms in the CCL2 gene have been shown to influence the bone marrow microenvironment in MPN, with homozygosity for the CCL2 rs1024611 SNP linked to diminished survival in individuals with primary myelofibrosis (119). The gene discussed is CCL2; the disease is myeloproliferative disorder.